Nabil V. Sayour

Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation

Alex Ali Sayour, Sevil Korkmaz‐Icöz, Sivakkanan Loganathan et al. · Journal of Translational Medicine · 2019 · 126 citations · Full text

Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment

Tamás G. Gergely, Dániel Kucsera, Viktória É. Tóth et al. · British Journal of Pharmacology · 2022 · 56 citations · Full text

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

Nabil V. Sayour, Ágnes Paál, Pietro Ameri et al. · European Heart Journal · 2024 · 30 citations · Full text

Cardiovascular Toxicity, Heart Failure, Oncology +14

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion

Gábor B. Brenner, András Makkos, Csilla Terézia Nagy et al. · Cells · 2020 · 25 citations · Full text

IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH

Dániel Kucsera, Viktória É. Tóth, Nabil V. Sayour et al. · Scientific Reports · 2023 · 19 citations · Full text